v3.25.1
Share based payments
12 Months Ended
Dec. 31, 2024
Share based payments  
Share based payments

32. Share based payments

SUBSCRIPTION RIGHT PLANS

Presented below is a summary of subscription right activities for the reported periods. Various subscription right plans were approved by the Board of Directors for the benefit of our employees, and for members of the Executive Committee and of the Board of Directors and independent consultants.

The subscription rights offered to members of the Board of Directors vest over a period of 36 months at a rate of 1/36th per month. Effective January 1, 2020, we no longer grant subscription rights to members of the Board of Directors (Non-Executive Directors), taking into account the stricter rules of the Belgian Companies Code and 2020 Corporate Governance Code.

Within the framework of the authorized capital and for the benefit of the Executive Committee members and employees of the Galapagos group, the Board of Directors issued “Subscription Right Plan 2024 BE”, “Subscription Right Plan 2024 RMV” and “Subscription Right Plan 2024 ROW”, for a total of 1,340,000 subscription rights (after acceptance by the beneficiaries) on May 16, 2024, and for a total of 41,000 subscription rights (after acceptance by the beneficiaries) on October 1, 2024.

Following table shows when a subscription right becomes exercisable, per issued plan:

Subscription right exercisable as from:

Cliff vesting

Graded vesting

    

First tranche of 25%

Second tranche of 25%

Third tranche of 50%

Subscription right plans before 2021

First day after end of third calendar year following the grant

Subscription right plan 2021BE

First day after end of third calendar year following the grant

Subscription right plan 2021RMV and ROW

January 1, 2023

January 1, 2024

January 1, 2025

Subscription right plan 2022 (A)

January 1, 2023

January 1, 2024

January 1, 2025

Subscription right plan 2022 (B)

January 1, 2026

Subscription right plan 2022BE

January 1, 2026

Subscription right plan 2022RMV and ROW

January 1, 2024

January 1, 2025

January 1, 2026

Subscription right plan 2023BE

January 1, 2027

Subscription right plan 2023RMV and ROW

-

January 1, 2025

January 1, 2026

January 1, 2027

Subscription right plan 2024BE

January 1, 2028

Subscription right plan 2024RMV and ROW

January 1, 2026

January 1, 2027

January 1, 2028

In the event of a change of control over Galapagos NV, all outstanding subscription rights vest immediately (to the extent they had not all vested yet) and will become immediately exercisable in accordance with the relevant subscription right plan rules.

The table below sets forth a summary of subscription rights outstanding and exercisable at December 31, 2024, per subscription right plan:

    

    

    

    

Outstanding 

    

    

    

    

    

Outstanding 

    

Exercisable

 per

Granted and accepted

Exercised

Forfeited

Expired

per

per

Allocation

Expiry

Exercise

January 1,

during

during

during

during

December 31,

December 31,

Subscription right plan

date

date

price (€)

2024

the year

the year

the year

the year

2024

2024

2016

1/6/2016

05/31/2024

46.10

325,500

(325,500)

2016 RMV

1/6/2016

05/31/2024

46.10

69,000

(69,000)

2016 (B)

01/20/2017

01/19/2025

62.50

10,000

10,000

10,000

2017

05/17/2017

05/16/2025

80.57

585,000

585,000

585,000

2017 RMV

05/17/2017

05/16/2025

80.57

122,500

(17,500)

105,000

105,000

2018

04/19/2018

04/18/2026

79.88

964,995

(35,000)

929,995

929,995

2018 RMV

04/19/2018

04/18/2026

79.88

132,500

(15,000)

117,500

117,500

2019

10/4/2019

9/4/2027

95.11

1,208,240

(63,250)

1,144,990

1,144,990

2019 RMV

10/4/2019

9/4/2027

95.11

177,250

(23,750)

153,500

153,500

2020

04/17/2020

04/16/2028

168.42

1,369,617

(53,925)

1,315,692

1,315,692

2020RMV

04/17/2020

04/16/2028

168.42

193,300

(14,125)

179,175

179,175

2021BE

04/30/2021

04/29/2029

64.76

1,032,606

(17,573)

1,015,033

2021RMV

04/30/2021

04/29/2029

64.76

226,296

(7,371)

218,925

109,258

2021ROW

04/30/2021

04/29/2029

64.76

667,496

(76,046)

591,450

295,498

2022 (A)

01/13/2022

12/1/2030

46.18

30,000

30,000

15,000

2022 (B)

01/26/2022

01/25/2030

50.00

1,000,000

1,000,000

2022BE

6/5/2022

5/5/2030

57.46

817,828

(13,596)

804,232

2022BE

5/8/2022

5/5/2030

51.58

78,000

78,000

2022RMV

6/5/2022

5/5/2030

57.46

203,464

(4,395)

199,069

49,672

2022ROW

6/5/2022

5/5/2030

57.46

705,500

(74,400)

631,100

157,661

2022ROW

5/8/2022

4/8/2030

51.58

60,000

60,000

15,000

2023BE

5/5/2023

4/5/2031

35.11

609,028

(15,778)

593,250

2023RMV

5/5/2023

4/5/2031

35.11

102,500

(2,500)

100,000

2023ROW

5/5/2023

4/5/2031

35.11

561,900

(65,000)

496,900

2023BE

06/15/2023

06/14/2031

38.58

200,000

200,000

2023ROW

11/17/2023

4/5/2031

32.99

20,000

20,000

2024BE

05/16/2024

05/15/2032

26.90

679,000

(11,202)

667,798

2024RMV

05/16/2024

05/15/2032

26.90

21,500

21,500

2024ROW

05/16/2024

05/15/2032

26.90

639,500

(37,500)

602,000

2024BE

1/10/2024

09/30/2032

25.88

3,500

3,500

2024ROW

1/10/2024

09/30/2032

25.88

37,500

37,500

Total

11,472,520

1,381,000

(547,911)

(394,500)

11,911,109

5,182,941

    

    

Weighted

average

exercise

Subscription rights

price (Euro)

Outstanding on December 31, 2021

8,579,837

92.69

Exercisable on December 31, 2021

1,751,013

56.64

Granted and accepted during the period

3,127,239

54.71

Forfeited during the year

(607,430)

100.00

Exercised during the period

(282,790)

23.68

Expired during the year

Outstanding on December 31, 2022

10,816,856

83.12

Exercisable on December 31, 2022

2,574,218

70.26

Granted and accepted during the period

1,538,400

35.53

Forfeited during the year

(544,676)

80.31

Exercised during the period

(61,560)

28.75

Expired during the year

(276,500)

49.00

Outstanding on December 31, 2023

11,472,520

77.93

Exercisable on December 31, 2023

5,836,538

101.93

Granted and accepted during the period

1,381,000

26.87

Forfeited during the year

(547,911)

72.66

Exercised during the period

Expired during the year

(394,500)

46.10

Outstanding on December 31, 2024

11,911,109

73.19

Exercisable on December 31, 2024

5,182,941

107.03

The table below sets forth the inputs into the valuation of the subscription rights.

2024BE/ROW

2024BE

    

2024RMV/ROW

2023BE

2023RMV/ROW

October 1

    

May 16

    

May 16

    

May 5 & June 15

    

May 5 & November 17

Weighted average exercise price (€)

25.88

26.90

26.90

35.97

35.05

Weighted average share price at acceptance date (€)

26.00

23.80

23.80

38.53

38.63

Weighted average fair value at the acceptance date (€)

10.57

9.78

9.11

16.61

15.96

Weighted average historical (2024)/estimated (before 2024) volatility (%)

41.73

42.19

42.19

36.89

36.67

Weighted average expected life of the subscription rights (years)

5.28

6.22

5.44

6.14

5.38

Weighted average risk free rate (%)

2.17

2.56

2.58

2.77

2.74

Expected dividends

None

None

None

None

None

2022 (A)

2022 (B)

2022BE

2022 RMV/ROW

2022BE/ROW

January 13

    

January 26

    

May 6

    

May 6

    

August 6

Exercise Price (€)

46.18

50.00

57.46

57.46

51.58

Weighted average share price at acceptance date (€)

46.21

56.67

51.64

51.64

44.55

Weighted average fair value at the acceptance date (€)

16.10

24.53

20.73

18.92

17.07

Weighted average historical (2024)/estimated (before 2024) volatility (%)

41.80

40.80

42.59

42.65

41.75

Weighted average expected life of the subscription rights (years)

4.72

5.95

6.37

5.36

5.68

Weighted average risk free rate (%)

(0.13)

0.67

1.33

1.26

2.70

Expected dividends

None

None

None

None

None

The exercise price of the subscription rights is determined pursuant to the applicable provisions of the Belgian Law of March 26, 1999.

The weighted average estimated volatility is calculated on the basis of the implied volatility of the share price over the weighted average expected life of the subscription rights. For the plans issued in 2024 we used the historical volatility.

The weighted average expected life of the subscription right is calculated as the estimated duration until exercise, taking into account the specific features of the plans. For the plans issued in 2024 we assumed an exercise at mid-point.

Our share based compensation expense in 2024 in relation to subscription right plans amounted to €19,886 thousand (2023: €56,718 thousand; 2022: €88,506 thousand), of which €17,685 thousand (2023: €36,628 thousand, 2022: €62,003 thousand) from continuing operations and €2,201 thousand (2023: €20,090 thousand, 2022: 26,503 thousand) from discontinued operations.

The following table provides an overview of the outstanding subscription rights per category of subscription right holders at December 31, 2024, 2023 and 2022.

Category

December 31,

    

2024

    

2023

    

2022

(in number of subscription rights)

Members of the Board of Directors

7,500

7,500

75,000

Members of the Executive Committee

1,616,500

1,670,500

1,864,000

Personnel

10,287,109

9,794,520

8,877,856

Total subscription rights outstanding

11,911,109

11,472,520

10,816,856

The outstanding subscription rights at the end of the accounting period have an weighted average exercise price of €73.19 (2023: €77.93; 2022: €83.10) and a weighted average remaining expected life of 1,560 days (2023: 1,728 days; 2022: 1,914 days).

RESTRICTED STOCK UNITS RSUs

Each RSU represents the right to receive, at our discretion, one Galapagos share or a payment in cash of an amount equivalent to the volume-weighted average price of the Galapagos share on Euronext Brussels over the 30-calendar day period preceding the relevant vesting date, in accordance with the terms and conditions of the relevant RSU program.

We currently have the following restricted stock unit (RSU) programs:

Plan 2020.I, Plan 2021.I and Plan 2022.I, Plan 2023.I and Plan 2024.I: these plans are intended to provide a long-term incentive to certain of our employees and members of the Executive Committee;
Plan 2020.II, Plan 2021.II, Plan 2021.IV, Plan 2022.II, Plan 2023.II and Plan 2024.II: these plans are designed with the aim to retain a specific group of our key employees and members of the Executive Committee whose retention is considered so important for our future performance that an additional incentive is desired. The beneficiaries are nominated by the Remuneration Committee and the Board of Directors approves the list of beneficiaries. The four-year vesting period is designed to be aligned with long-term shareholder interests; 
Plan 2021.III and Plan 2022.III: these plans are intended to compensate employees who transferred from Gilead to us in the framework of the transfer of European commercialization rights for the long-term incentive plans within Gilead under which unvested RSU awards lapsed upon transfer out of the Gilead group. These employees received a one-time Restricted Stock Units grant from us.

The main characteristics of all these plans are as follows:

the RSUs are offered for no consideration;
generally four-year vesting period, with 25% vesting each year, except for some plans or some beneficiaries for which the RSUs will all vest at the same time three years after the offer date (bullet vesting); vest 50% after two years and 50% after three years or vest over three years with 34% vesting the first year and 33% in each of the remaining two years;
payout will be in cash or shares, at our discretion, it being understood that in respect of members of the Executive Committee, any vesting prior to the third anniversary of the offer date will always give rise to a payment in cash rather than a delivery of shares;
any unvested RSUs are forfeited upon termination of service before the vesting date.

The table below sets forth a summary of RSUs outstanding at December 31, 2024, per RSU plan:

    

    

Outstanding 

    

    

    

    

Outstanding 

 per

Granted

Forfeited

Paid in cash

per

Offer

January 1,

during

during

during

December 31,

RSU plan

date

2024

year

year

year

2024

Plan 2020.I.

6/5/2020

5,191

(2,490)

(2,701)

Plan 2020.II.

7/5/2020

2,761

(239)

(2,522)

Plan 2021.I.

5/5/2021

42,829

(22,968)

(11,413)

8,448

Plan 2021.II.

5/6/2021

9,478

(4,739)

(2,708)

2,031

Plan 2021.III.

06/03/2021-08/06/2021

5,416

(5,416)

Plan 2021.IV.

09/24/2021

15,430

(7,715)

(7,715)

Plan 2022.I.

3/5/2022

103,308

(64,066)

(15,410)

23,832

Plan 2022.II.

5/05/2022 - 8/05/2022

106,128

(22,832)

(28,528)

54,768

Plan 2022.III.

7/6/2022

5,530

(5,530)

Plan 2023.I.

8/5/2023

366,582

(191,532)

(45,087)

129,963

Plan 2023.II.

05/09/2023 - 06/15/2023 - 11/17/2023

512,800

(108,471)

(116,704)

287,625

Plan 2024.I.

05/16/2024

588,216

(21,760)

566,456

Plan 2024.II.

05/16/2024 - 09/17/2024

251,872

(18,724)

233,148

Total

1,175,453

840,088

(476,482)

(232,788)

1,306,271

2024

    

2023

2022

(in number of RSUs)

Outstanding on January 1,

1,175,453

736,095

657,803

Granted during the year

840,088

920,510

470,273

Forfeited during the year

(476,482)

(270,474)

(172,885)

Paid in cash during the year

(232,788)

(210,678)

(219,096)

Outstanding on December 31,

1,306,271

1,175,453

736,095

The RSUs are measured based on the volume-weighted average price of the Galapagos share on Euronext Brussels over the 30-calendar day period preceding the reporting period and they are re-measured at each reporting date. We recognize the corresponding expense and liability over the vesting period. The total liability relating to outstanding RSUs on December 31, 2024 amounted to €16.7 million (2023: €13.8 million, 2022: €12.9 million).

The following table provides an overview of the outstanding RSUs per category of RSU holders on December 31, 2024, 2023 and 2022.

December 31,

    

2024

    

2023

    

2022

(in number of RSUs)

Members of the Executive Committee

564,034

438,738

332,038

Personnel

742,237

736,715

404,057

Total outstanding RSUs

1,306,271

1,175,453

736,095